Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients
Copyright © 2023 Rubinstein, Kudryavtsev, Malkova, Mammedova, Isakov, Isakova-Sivak, Kudlay and Starshinova..
Currently, there are a large number of reports about the development of autoimmune conditions after COVID-19. Also, there have been cases of sarcoid-like granulomas in convalescents as a part of the post-COVID-19 syndrome. Since one of the etiological theories of sarcoidosis considers it to be an autoimmune disease, we decided to study changes in the adaptive humoral immune response in sarcoidosis and SARS-CoV-2 infection and to find out whether COVID-19 can provoke the development of sarcoidosis. This review discusses histological changes in lymphoid organs in sarcoidosis and COVID-19, changes in B cell subpopulations, T-follicular helper cells (Tfh), and T-follicular regulatory cells (Tfr), and analyzes various autoantibodies detected in these pathologies. Based on the data studied, we concluded that SARS-CoV-2 infection may cause the development of autoimmune pathologies, in particular contributing to the onset of sarcoidosis in convalescents.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Frontiers in medicine - 10(2023) vom: 26., Seite 1271198 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rubinstein, Artem [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autoantibodies |
---|
Anmerkungen: |
Date Revised 06.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fmed.2023.1271198 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366698974 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366698974 | ||
003 | DE-627 | ||
005 | 20240108142708.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fmed.2023.1271198 |2 doi | |
028 | 5 | 2 | |a pubmed24n1250.xml |
035 | |a (DE-627)NLM366698974 | ||
035 | |a (NLM)38179278 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rubinstein, Artem |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 06.01.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2023 Rubinstein, Kudryavtsev, Malkova, Mammedova, Isakov, Isakova-Sivak, Kudlay and Starshinova. | ||
520 | |a Currently, there are a large number of reports about the development of autoimmune conditions after COVID-19. Also, there have been cases of sarcoid-like granulomas in convalescents as a part of the post-COVID-19 syndrome. Since one of the etiological theories of sarcoidosis considers it to be an autoimmune disease, we decided to study changes in the adaptive humoral immune response in sarcoidosis and SARS-CoV-2 infection and to find out whether COVID-19 can provoke the development of sarcoidosis. This review discusses histological changes in lymphoid organs in sarcoidosis and COVID-19, changes in B cell subpopulations, T-follicular helper cells (Tfh), and T-follicular regulatory cells (Tfr), and analyzes various autoantibodies detected in these pathologies. Based on the data studied, we concluded that SARS-CoV-2 infection may cause the development of autoimmune pathologies, in particular contributing to the onset of sarcoidosis in convalescents | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a B-cell | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a autoantibodies | |
650 | 4 | |a autoimmunity | |
650 | 4 | |a follicular Th | |
650 | 4 | |a follicular Treg | |
650 | 4 | |a post-COVID-19 syndrome | |
650 | 4 | |a sarcoidosis | |
700 | 1 | |a Kudryavtsev, Igor |e verfasserin |4 aut | |
700 | 1 | |a Malkova, Annа |e verfasserin |4 aut | |
700 | 1 | |a Mammedova, Jennet |e verfasserin |4 aut | |
700 | 1 | |a Isakov, Dmitry |e verfasserin |4 aut | |
700 | 1 | |a Isakova-Sivak, Irina |e verfasserin |4 aut | |
700 | 1 | |a Kudlay, Dmitry |e verfasserin |4 aut | |
700 | 1 | |a Starshinova, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in medicine |d 2014 |g 10(2023) vom: 26., Seite 1271198 |w (DE-627)NLM245390847 |x 2296-858X |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2023 |g day:26 |g pages:1271198 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fmed.2023.1271198 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2023 |b 26 |h 1271198 |